График акции Profound Medical Corp.
Расширенный график
Простой график
О компании
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. Подробнее| Цена ао | 8.15 |
|---|---|
| Выручка | 0.0042 |
| EBITDA | -0.0132 |
| Число акций ао | 0.02118 млрд |
| P/S | 27.02 |
| P/BV | 8 |
| EV/EBITDA | -8.36 |
| ISIN | CA74319B5027 |
| Сайт | https://www.profoundmedical.com |
| Валюта | usd |
| IPO date | 2016-06-09 |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Валюта отчета | usd |
| Изменение цены за день: | 0% (7.63) |
|---|---|
| Изменение цены за неделю: | +0.778% (7.5711) |
| Изменение цены за месяц: | -1.17% (7.72) |
| Изменение цены за 3 месяца: | -23.62% (9.99) |
| Изменение цены за полгода: | -1.55% (7.75) |
| Изменение цены за год: | -18.31% (9.34) |
| Изменение цены за 3 года: | -44.43% (13.73) |
| Изменение цены за 5 лет: | +723.62% (0.9264) |
| Изменение цены с начала года: | -25.99% (10.31) |
|
|
Недооценка
|
Эффективность
|
|||||||||||||||||||||||||||||||||||||
Дивиденды
|
Долг
|
Импульс роста
|
|||||||||||||||||||||||||||||||||||||
| Институционалы | Объем | Доля, % |
|---|---|---|
| Gagnon Securities, LLC | 1541576 | 6.31 |
| FIL LTD | 1200635 | 4.91 |
| Letko, Brosseau & Associates Inc. | 1177850 | 4.82 |
| Gagnon Advisors, LLC | 679296 | 2.78 |
| AIGH Capital Management LLC | 646733 | 2.65 |
| Raymond James Financial Services Advisors, Inc. | 622552 | 2.55 |
| Timelo Investment Management Inc. | 611758 | 2.5 |
| Royce & Associates LP | 564298 | 2.31 |
| Rosalind Advisors, Inc. | 533333 | 2.18 |
| Royal Bank of Canada | 400159 | 1.64 |
| Руководитель | Должность | Оплата | Год рождения |
|---|---|---|---|
| Dr. Arun Swarup Menawat MBA, Ph.D. | Chairman of the Board & CEO | 435.87k | 1955 (69 лет) |
| Mr. Rashed Dewan | Chief Financial Officer | 215.18k | 1968 (56 лет) |
| Mr. Hartmut Warnken | Senior Vice President for Strategic Alliances | 226.17k | 1973 (51 год) |
| Dr. Mathieu Burtnyk | Chief Operating Officer | 215.18k | 1982 (42 года) |
| Mr. Stephen Kilmer | Investor Relations | N/A | |
| Mr. Jacques F. Cornet | VP of International Sales & Marketing | N/A | 1956 (68 лет) |
| Mr. Matthew Sobczyk C.A., CPA | Assistant Corporate Controller | N/A | |
| Mr. Levant Tinaz | Software Developer | N/A | |
| Ms. Abbey Goodman | Chief Commercial Officer of Global | 1983 (41 год) |
Адрес: Canada, Mississauga. ON LW K, 2400 Skymark Avenue - открыть в Google картах, открыть Яндекс картах
Сайт: https://www.profoundmedical.com
Сайт: https://www.profoundmedical.com
